|
Report Date : |
28.05.2012 |
IDENTIFICATION DETAILS
|
Name : |
VEDIC FANXIPANG PHARMA CHEMIC COMPANY
LIMITED |
|
|
|
|
Registered Office : |
Lot D Le Mon IP, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.12.2011 |
|
|
|
|
Year of Establishment : |
2006 |
|
|
|
|
Legal Form : |
Limited Liability Company |
|
|
|
|
Line of Business : |
manufacture and export of
artemisinin |
|
|
|
|
No. of Employees : |
17 |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Status : |
Moderate |
|
Payment Behaviour : |
No Complaints |
|
Litigation : |
Clear |
NOTES:
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2012
|
Country Name |
Previous Rating (31.12.2011) |
Current Rating (31.03.2012) |
|
|
B1 |
B1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
Current legal status
|
||
|
English Name |
|
VEDIC FANXIPANG PHARMA CHEMIC COMPANY
LIMITED |
|
Vietnamese Name |
|
CONG TY TNHH HOA DUOC VEDIC FANXIPANG |
|
Type of Business |
|
Limited liability company |
|
Year Established |
|
2006 |
|
Investment Certificate No |
|
262023000098 |
|
Date Of Issuance |
|
19 May 2011 |
|
Place of Issuance |
|
Nghi Son Industrial Zone Authority |
|
Registered Investment Capital |
|
USD 4,300,000 |
|
Chartered capital |
|
USD 3,000,000 |
|
Status |
|
Unlisted |
|
Tax code |
|
2800936472 |
|
Total Employees |
|
17 |
|
Size |
|
Small |
Historical
Identification & Legal form
|
List |
Changed Items |
Date of changes |
|
1 |
Subject has got former Shareholders: Fanxipang
Construction and Investment Joint Stock Company (in Changed to: Sequent Scientific Company
Limited (in |
19
May 2011 |
|
Head Office |
||
|
Address |
|
Lot D Le Mon IP, |
|
Telephone |
|
(84-37) 3913443 |
|
Fax |
|
(84-37) 3913442 |
|
1.
NAME |
|
Mr.
LE NHAT THANG |
|
Position |
|
General Director |
|
Date of Birth |
|
02 Apr 1978 |
|
ID Number/Passport |
|
011899573 |
|
ID Issue Date |
|
04 Dec 2006 |
|
|
|
Hanoi Police Station |
|
Resident |
|
No 125 Yen Lac, Hai
Ba Trung District, Ha Noi City, Vietnam |
|
Nationality |
|
Vietnamese |
|
|
||
|
2.
NAME |
|
Ms.
DANG MINH NGUYET |
|
Position |
|
Chief Accountant |
|
Nationality |
|
Vietnamese |
|
Tel/Mobil phone |
|
++84978 360 999 |
|
Email |
|
|
|
The subject
is specializing in manufacture and export of artemisinin. |
|
IMPORT: |
||
|
Note: Currently, the subject does not import |
||
|
|
||
|
EXPORT: |
||
|
·
Types of products |
|
artemisinin |
|
·
Market |
|
|
|
·
Ratio |
|
100% |
|
1.
VIET NAM BANK FOR AGRICULTURE AND RURAL DEVELOPMENT BA DINH BRANCH |
||
|
Address |
|
Ba |
|
1.
NAME |
|
VEDIC
ELEMENTS PRIVATE COMPANY LIMITED |
|
Business Registration |
|
08/26027 |
|
Address |
|
Strides House Bilekanalli Bannerghatta |
|
Value of shares |
|
USD 2,700,000 |
|
Percentage |
|
90% |
|
|
||
|
2.
NAME |
|
SEQUENT
SCIENTIFIC COMPANY LIMITED |
|
Business Registration |
|
L99999MH1985PL036685 |
|
Address |
|
No 116 Vardharnan INDL Complex, LBS Marg,
Thane West, |
|
Value of shares |
|
VND 300,000 |
|
Percentage |
|
10% |
|
|
||
|
BALANCE
SHEET |
||
Unit: One VND
|
||
|
Balance sheet
date |
31/12/2011 |
31/12/2010 |
|
Number of weeks |
52 |
52 |
|
ASSETS |
||
|
A – CURRENT
ASSETS |
36,945,181,285
|
33,755,890,346
|
|
I. Cash and cash
equivalents |
6,442,142,711
|
15,548,485,361
|
|
1. Cash |
6,442,142,711 |
15,548,485,361 |
|
2. Cash equivalents |
0 |
0 |
|
II. Short-term
investments |
0 |
0 |
|
1. Short-term investments |
0 |
0 |
|
2. Provisions for devaluation of short-term investments |
0 |
0 |
|
III. Accounts
receivable |
10,944,374,888
|
283,483,422
|
|
1. Receivable from customers |
0 |
0 |
|
2. Prepayments to suppliers |
10,944,374,888 |
161,154,876 |
|
3. Inter-company receivable |
0 |
0 |
|
4. Receivable according to the progress of construction |
0 |
0 |
|
5. Other receivable |
0 |
122,328,546 |
|
6. Provisions for bad debts |
0 |
0 |
|
IV. Inventories |
19,080,693,652
|
17,175,843,494
|
|
1. Inventories |
19,080,693,652 |
17,175,843,494 |
|
2. Provisions for devaluation of inventories |
0 |
0 |
|
V. Other Current
Assets |
477,970,034
|
748,078,069
|
|
1. Short-term prepaid expenses |
0 |
0 |
|
2. VAT to be deducted |
477,970,034 |
748,078,069 |
|
3. Taxes and other accounts receivable from the State |
0 |
0 |
|
4. Other current assets |
0 |
0 |
|
B. LONG-TERM
ASSETS |
14,464,341,728
|
9,632,368,515
|
|
I. Long term
accounts receivable |
0 |
0 |
|
1. Long term account receivable from customers |
0 |
0 |
|
2. Working capital in affiliates |
0 |
0 |
|
3. Long-term inter-company receivable |
0 |
0 |
|
4. Other long-term receivable |
0 |
0 |
|
5. Provisions for bad debts from customers |
0 |
0 |
|
II. Fixed assets
|
14,225,184,124
|
9,379,944,951
|
|
1. Tangible assets |
14,225,184,124 |
9,379,944,951 |
|
- Historical costs |
18,659,374,654 |
12,654,901,465 |
|
- Accumulated depreciation |
-4,434,190,530 |
-3,274,956,514 |
|
2. Financial leasehold assets |
0 |
0 |
|
- Historical costs |
0 |
0 |
|
- Accumulated depreciation |
0 |
0 |
|
3. Intangible assets |
0 |
0 |
|
- Initial costs |
0 |
0 |
|
- Accumulated amortization |
0 |
0 |
|
4. Construction-in-progress |
0 |
0 |
|
III. Investment
property |
0 |
0 |
|
Historical costs |
0 |
0 |
|
Accumulated depreciation |
0 |
0 |
|
IV. Long-term
investments |
0 |
0 |
|
1. Investments in affiliates |
0 |
0 |
|
2. Investments in business concerns and joint ventures |
0 |
0 |
|
3. Other long-term investments |
0 |
0 |
|
4. Provisions for devaluation of long-term investments |
0 |
0 |
|
V. Other
long-term assets |
239,157,604
|
252,423,564
|
|
1. Long-term prepaid expenses |
0 |
0 |
|
2. Deferred income tax assets |
0 |
0 |
|
3. Other long-term assets |
239,157,604 |
252,423,564 |
|
VI. Goodwill |
0 |
0 |
|
1. Goodwill |
0 |
0 |
|
TOTAL ASSETS |
51,409,523,013
|
43,388,258,861
|
|
|
||
|
LIABILITIES |
||
|
A- LIABILITIES |
26,495,880,054
|
14,644,885,435
|
|
I. Current
liabilities |
4,489,097,733
|
1,392,485,435
|
|
1. Short-term debts and loans |
0 |
0 |
|
2. Payable to suppliers |
2,146,683,432 |
1,307,311,787 |
|
3. Advances from customers |
685,807,513 |
0 |
|
4. Taxes and other obligations to the State Budget |
1,683,528 |
1,683,528 |
|
5. Payable to employees |
0 |
0 |
|
6. Accrued expenses |
1,654,923,260 |
83,490,120 |
|
7. Inter-company payable |
0 |
0 |
|
8. Payable according to the progress of construction contracts |
0 |
0 |
|
9. Other payable |
0 |
0 |
|
10. Provisions for short-term accounts payable |
0 |
0 |
|
II. Long-Term
Liabilities |
22,006,782,321
|
13,252,400,000
|
|
1. Long-term accounts payable to suppliers |
0 |
0 |
|
2. Long-term inter-company payable |
0 |
0 |
|
3. Other long-term payable |
0 |
0 |
|
4. Long-term debts and loans |
22,006,782,321 |
13,252,400,000 |
|
5. Deferred income tax payable |
0 |
0 |
|
6. Provisions for unemployment allowances |
0 |
0 |
|
7. Provisions for long-term accounts payable |
0 |
0 |
|
B- OWNER’S
EQUITY |
24,913,642,959
|
28,743,373,426
|
|
I. OWNER’S
EQUITY |
24,913,642,959
|
28,743,373,426
|
|
1. Capital |
47,179,436,808 |
45,127,368,601 |
|
2. Share premiums |
0 |
0 |
|
3. Other sources of capital |
0 |
0 |
|
4. Treasury stocks |
0 |
0 |
|
5. Differences on asset revaluation |
0 |
0 |
|
6. Foreign exchange differences |
0 |
0 |
|
7. Business promotion fund |
0 |
0 |
|
8. Financial reserved fund |
0 |
0 |
|
9. Other funds |
0 |
0 |
|
10. Retained earnings |
-22,265,793,849 |
-16,383,995,175 |
|
11. Construction investment fund |
0 |
0 |
|
II. Other
sources and funds |
0 |
0 |
|
1. Bonus and welfare funds |
0 |
0 |
|
2. Sources of expenditure |
0 |
0 |
|
3. Fund to form fixed assets |
0 |
0 |
|
MINORITY’S
INTEREST |
0 |
0 |
|
TOTAL
LIABILITIES AND OWNER’S EQUITY |
51,409,523,013
|
43,388,258,861
|
|
PROFIT
& LOSS STATEMENT |
||
|
|
||
|
Description |
FY2011 |
FY2010 |
|
1. Total Sales |
23,424,648,000
|
0 |
|
2. Deduction item |
0 |
0 |
|
3. Net revenue |
23,424,648,000
|
0 |
|
4. Costs of goods sold |
23,566,664,525 |
0 |
|
5. Gross profit |
-142,016,525
|
0 |
|
6. Financial income |
1,390,863,255 |
43,544,705 |
|
7. Financial expenses |
2,999,877,727 |
67,775,134 |
|
- In which: Loan interest expenses |
1,654,944,680 |
0 |
|
8. Selling expenses |
0 |
0 |
|
9. Administrative overheads |
4,361,795,953 |
535,455,976 |
|
10. Net operating profit |
-6,112,826,950
|
-559,686,405
|
|
11. Other income |
473,612,115 |
|
|
12. Other expenses |
242,583,839 |
995,596,597 |
|
13. Other profit /(loss) |
231,028,276
|
-995,596,597
|
|
14. Total accounting profit before tax |
-5,881,798,674
|
-1,555,283,002
|
|
15. Current corporate income tax |
0 |
0 |
|
16. Deferred corporate income tax |
0 |
0 |
|
17. Interest from subsidiaries/related companies |
|
0 |
|
18. Profit after tax |
-5,881,798,674
|
-1,555,283,002
|
|
FINANCIAL RATIOS
AND AVERAGE INDUSTRY RATIOS |
|||
|
|
|||
|
Description |
FY2011 |
FY2010 |
Average Industry |
|
Current liquidity ratio |
8.23 |
24.24 |
1.65 |
|
Quick liquidity ratio |
3.98 |
11.91 |
1.04 |
|
Inventory circle |
1.30 |
- |
4.14 |
|
Average receive period |
170.53 |
- |
105.37 |
|
Utilizing asset performance |
0.46 |
- |
1.20 |
|
Liability by total assets |
51.54 |
33.75 |
53.11 |
|
Liability by owner's equity |
106.35 |
50.95 |
159.74 |
|
Ebit / Total assets (ROA) |
-8.22 |
-3.58 |
10.37 |
|
Ebit / Owner's equity (ROE) |
-16.97 |
-5.41 |
23.03 |
|
Ebit / Total revenue (NPM) |
-18.04 |
- |
10.15 |
|
Gross profit / Total revenue (GPM) |
-0.61 |
- |
25.88 |
|
Note: The Average Industry
was calculated by VietnamCredit based on our own statistical data |
|||
|
CASH
FLOW STATEMENT |
||
|
(Direct method) |
||
|
Items |
FY2011 |
FY2010 |
|
I. Cash flows
from operating activities |
||
|
1.Cash received from customers |
24,398,174,443 |
|
|
2. Cash paid to suppliers |
-37,479,072,937 |
-45,969,621 |
|
3. Cash paid to employees |
-1,445,809,078 |
-360,000,000 |
|
4. Interest paid |
|
|
|
5. Income taxes paid |
|
|
|
6. Other operating cash receipts |
2,195,255,096 |
|
|
7. Other operating payments |
-64,657,640 |
|
|
Net cash flows from operating activities |
-12,396,110,116 |
-405,969,621 |
|
II. Cash flows
from investing activities |
||
|
1. Purchases and construction of fixed assets and other long-term
assets |
-6,004,473,189 |
-14,264,000 |
|
2. Gains from disposals and liquidation of fixed assets and other
long-term assets |
|
|
|
3. Loans given and purchases of debt instruments of other entities |
|
|
|
4. Recovery of loans given and disposals of debt instruments of other
entities |
|
|
|
5. Investments into other entities |
|
|
|
6. Withdrawals of investments in other entities |
|
|
|
7. Receipts of loan interests, dividends and profit shared |
22,265,218 |
|
|
Net cash flows from investing activities |
-5,982,207,971 |
-14,264,000 |
|
III. Cash flows
from financing activities |
||
|
1. Gains from stock issuance and capital contributions from
shareholders |
2,052,068,207 |
2,153,814,876 |
|
2. Repayment for capital contributions and re-purchases of stocks already
issues |
|
|
|
3. Short-term and long-term loans received |
12,347,500,000 |
13,252,400,000 |
|
4. Loan principal amounts repaid |
-5,075,018,103 |
|
|
5. Payments for financial leasehold assets |
|
|
|
6. Dividends and profit already paid to the owners |
|
|
|
Net cash flows from financing activities |
9,324,550,104 |
15,406,214,876 |
|
Net cash flows during the year |
-9,053,767,983 |
14,985,981,255 |
|
Beginning cash and cash equivalents |
15,548,485,361 |
941,131,975 |
|
Effects of fluctuations in foreign exchange rates |
-52,574,667 |
35,098,531 |
|
Ending cash and cash equivalents |
6,442,142,711 |
15,962,211,761 |
|
Trade Morality |
|
|
|
Liquidity |
|
High |
|
Payment status |
|
Average |
|
Financial Situation |
|
Average |
|
Development trend |
|
Negative |
|
Litigation data |
|
No Record |
|
Bankruptcy |
|
No Record |
|
Payment Methods |
|
TT and LC |
|
|
|
To contracts |
|
Public opinion |
|
|
|
VEDIC FANXIPANG PHARMA CHEMIC COMPANY
LIMITED was established in 2006 as a joint venture
company between Business of the
subject is manufacture and export of artemisinin. It is using in the
treatment of malaria and skin diseases. It has officially gone into
manufacture total system of the project since August 2011. All of products
are exported to Factory and head
office of the subject is at Lot D Le Mon IP, On the hand of
finance, the subject is assessed average. In 2010 the subject had not run
business officially yet, so it had not have revenue. Next to 2011, it reached
VND 23,424 million of total sale. Amounts of revenue and total asset are
normal comparison with its scale business. In the first years of
manufacturing, the subject still lost business and it is expected to get
profit in the coming time. In short, the
subject is still a new and small company in the field business. Its financial
strengthen is normal and it can meet small financial commitments. |
|
INDUSTRY DATA |
||||||
|
|
||||||
|
Industry code |
Growth speed by
price compared with 1994 (%) |
Total enterprises
2009 |
Total employees
2010 (Thous.pers.) |
Annual average
capital of enterprises 2009 (billion dongs) |
||
|
2011 |
2010 |
|||||
|
Agriculture,
Forestry and Fishing |
4.00 |
2.78 |
8,749 |
23,896.3 |
81,559 |
|
|
Industry and
Construction |
5.53 |
7.70 |
85,115 |
10,630 |
2,751,975 |
|
|
Trade and
Services |
6.69 |
7.52 |
154,978 |
14,522 |
4,939,069 |
|
|
|
||||||
|
ECONOMIC
INDICATORS |
||||||
|
|
||||||
|
|
2011 |
2010 |
2009 |
|||
|
Population (Million person) |
87.84 |
86.93 |
86.02 |
|||
|
Gross Domestic Products (USD
billion) |
119 |
102.2 |
91 |
|||
|
GDP Growth (%) |
5.89 |
6.78 |
5.32 |
|||
|
GDP Per Capita
(USD/person/year) |
1,300 |
1,160 |
1,080 |
|||
|
Inflation (% Change in
Composite CPI) |
18.58 |
11.75 |
6.88 |
|||
|
State Budget Deficit compared
with GDP (%) |
4.9 |
5.8 |
6.9 |
|||
|
|
||||||
|
SERVICE TRADE
PERFORMANCE |
||||||
|
|
||||||
|
Billion USD |
2011 |
2010 |
2009 |
|||
|
Exports |
96.3 |
72.2 |
57.1 |
|||
|
Imports |
105.8 |
84.8 |
69.9 |
|||
|
Trade Balance |
-9.5 |
-12.6 |
-12.8 |
|||
Source: General
Statistics Office
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.55.73 |
|
UK Pound |
1 |
Rs.87.26 |
|
Euro |
1 |
Rs.69.89 |
INFORMATION DETAILS
|
Report Prepared
by : |
MNL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.